Brain cancer

CRISPR Cas9
#Brain cancer #CRISPR #CRISPR screening #Oncology #The Institute of Cancer Research

CRISPR reveals new therapeutic target for glioblastoma

Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma rely on transforming growth factor beta-activated kinase 1 (TAK1) for survival and that inhibiting this enzyme leads to the death of the cells.  Furthermore, they have demonstrated that it is… Read More

#Cancer Research #News #Trending News

#Brain cancer #Genetic profiling #Machine learning #Oncology #Precision medicine #UCLA

ML study identifies new glioblastoma treatment strategy

A new precision medicine approach that combines genetic and functional profiling could predict how glioblastoma will respond to therapy.  A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma becomes resistant to treatment and introduces a new approach that paves… Read More

#Cancer Research #Editor's Choice #News

#Brain cancer #Cancer Research UK #Funding #Oncology #Paediatrics

£3m boost to paediatric brain cancer research

Experts from Cancer Research UK Children’s Brain Tumour Centre of Excellence in Cambridge, UK are set to share around £3.2 ($4.2) million to find and test better and less toxic ways to treat children’s brain tumours. The funding announcement comes during Childhood Cancer Awareness Month. Read More

#Cancer Research #News

Human brain
#Brain cancer #Dana-Farber Cancer Institute #Drug repurposing #Oncology #The Institute of Cancer Research

Breast cancer drug could treat rare childhood brain tumours

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found. A team of scientists from The Institute of Cancer Research, London and the Dana-Farber Cancer Institute, Boston, USA, have uncovered clues… Read More

#Cancer Research #Editor's Choice #News

#Brain cancer #FDA #hepatitis #PTSD #Regulatory #Solid tumours

New DDW Highlights podcast: 12 August 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news highlights this week all centre around significant US Food and Drug Administration… Read More

#News

#Brain cancer #FDA #hepatitis #PTSD #Regulatory #Solid tumours

New DDW Highlights vodcast: 12 August 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   The news highlights this week… Read More

#News

#Brain cancer #FDA #hepatitis #PTSD #Regulatory #Solid tumours

This week in drug discovery (5-9 August) 

News round-up for 5-9 August by DDW Senior Digital Content Editor Diana Spencer. The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approvals for drugs for solid tumours, hepatitis B and glioma. The top stories:… Read More

#News

MRI of the brain showing glioblastoma
#Brain cancer #FDA #Oncology #Servier Pharmaceuticals

FDA approves oral therapy for Grade 2 IDH-mutant glioma

The US Food and Drug Administration (FDA) has approved Voranigo, an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor, indicated for the treatment of patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma. It is approved in patients with a susceptible IDH1 or IDH2 mutation following surgery including… Read More

#News #Regulatory

MRI of the brain showing glioblastoma
#Brain cancer #Clinical trial #Drug repurposing #HIV #Oncology #University of Plymouth

Clinical trial to repurpose HIV drugs to treat brain tumours

Drugs developed to treat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours. Scientists at the Brain Tumour Research Centre of Excellence at the University of Plymouth are conducting a clinical trial to see whether using anti-retroviral medications, ritonavir… Read More

#Cancer Research #Editor's Choice #News

Herpes virus cells
#Brain cancer #CureSearch #Herpes virus #LifeArc #MD Anderson Cancer Center #Oncology #Paediatrics

Could a modified cold sore virus cure brain cancer?

A team of scientists in the US and the UK are combining a genetically modified cold sore virus with a cancer vaccine to treat an aggressive type of brain cancer in children. The three-year survival rate for children with high-grade gliomas, without further complications, is only… Read More

#Cancer Research #Editor's Choice #News

MRI showing glioblastoma
#Brain cancer #European Medicines Agency #FDA #Oncology #Orphan drugs

Regulatory update for malignant glioma drug

Carthera, a spin-off from Sorbonne University, has been granted Orphan Drug Designation (ODD) by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the use of carboplatin in the treatment of malignant glioma. Carthera is using carboplatin in the first registrational trial of its SonoCloud… Read More

#News #Regulatory

MRI showing glioblastoma
#Brain cancer #CAR-T #Cell therapy #Oncology #University of Pennsylvania

‘Dual-target’ CAR-T cell therapy shrinks brain tumours

Targeting two brain tumour-associated proteins – rather than one – with CAR-T cell therapy has shown promise as a strategy for reducing solid tumour growth in patients with recurrent glioblastoma (GBM). This is according to early results from the first six patients treated in an ongoing… Read More

#Cancer Research #News

Cancer cells
#Antibody #Brain cancer #Cancer research #CAR-T #CRISPR #Oncology

2023 cancer research highlights: Drug development at its best

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Figures from the Amercian Cancer Society1 state that “a little over… Read More

#Cancer Research #Exclusive Content

MRI showing glioblastoma
#Brain cancer #Oncology #Phase I trial #The Institute of Cancer Research #The Royal Marsden NHS Foundation Trust

‘Olive oil’ drug shows early promise in brain cancer

A drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. Results… Read More

#Cancer Research #News

Jennifer Doudna
#Brain cancer #Cancer research #CRISPR #CRISPR Therapeutics #Gladstone Institutes #Oncology

CRISPR ‘cancer shredding’ technique destroys brain tumours

Scientists have used CRISPR gene editing to target and rapidly destroy glioblastoma cells in an approach that could apply to other highly mutated cancers. Using a technique they’ve dubbed “cancer shredding,” the researchers at Gladstone Institutes programmed CRISPR to zero-in on repeating DNA sequences present only… Read More

#Cancer Research #Editor's Choice #News